Ovarian Low Grade Serous Adenocarcinoma

subtype

Identifier: CI-CAN-00008171
Entity page: /cancer/ovarian-low-grade-serous-adenocarcinoma ↗
Edges: 29

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Ovarian Low Grade Serous Adenocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 18show all (up to 200)
→ investigated in trials for	Doxorubicinsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Ovarian Low Grade Serous Adenocarcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Paclitaxel

Ovarian Low Grade Serous Adenocarcinoma studied in …STUDIED_INderived10 of 11show all (up to 200)
→ studied in	NCT07832227Phase 2 · not yet recruiting Imlunestrant/Abemaciclib/Selinexor in Ovarian and Endometrial · condition mapped ALIAS · 11 trials mapped (9 active)	—	—	Ovarian Low Grade Serous Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05554367Phase 2 · active not recruiting Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial · condition mapped ONTOLOGY_EXACT · 11 trials mapped (9 active)	—	—	Ovarian Low Grade Serous Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00488878recruiting Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors · condition mapped ALIAS · 11 trials mapped (9 active)	—	—	Ovarian Low Grade Serous Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07747506Phase 2 · not yet recruiting Continued Access to Avutometinib in Combination With Defactinib in Patients With Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) · condition mapped ALIAS · 11 trials mapped (9 active)	—	—	Ovarian Low Grade Serous Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02101788Phase 2/Phase 3 · completed Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer · condition mapped CURATED_BROADER · 11 trials mapped (9 active)	—	—	Ovarian Low Grade Serous Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04739800Phase 2 · active not recruiting Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents · condition mapped CURATED_BROADER · 11 trials mapped (9 active)	—	—	Ovarian Low Grade Serous Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04092270Phase 1 · active not recruiting A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer · condition mapped CURATED_BROADER · 11 trials mapped (9 active)	—	—	Ovarian Low Grade Serous Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06494150Phase 2 · active not recruiting Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO) · condition mapped ALIAS · 11 trials mapped (9 active)	—	—	Ovarian Low Grade Serous Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04095364Phase 3 · active not recruiting Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 11 trials mapped (9 active)	—	—	Ovarian Low Grade Serous Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04625270Phase 2 · active not recruiting A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation · condition mapped ALIAS · 11 trials mapped (9 active)	—	—	Ovarian Low Grade Serous Adenocarcinoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains